Featured Top

Madison Memory Study:

In a double-blinded, placebo-controlled trial, Prevagen demonstrated the ability to improve aspects of cognitive function in participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening. The group of participants taking Prevagen improved certain aspects of cognitive function according to computer-based testing. The adults were over 40 years old and took one capsule daily (10 mg) for 90 days.

View The Study

Madison Memory Study


Safety Study I

The main ingredient in Prevagen, apoaequorin, was evaluated for safety using a toxicity study, a common method for evaluating dietary supplements. In doses much higher than can be reasonably consumed (4,000 times the recommended daily amount of Prevagen Regular Strength) apoaequorin showed no adverse effects when taken orally.

Read The Summary

Safety Study II

In a separate safety study, Apoaequorin has not shown to have any significant risk of allergic reactivity when ingested.

Read The Summary



Safety Study III

In a third study conducted on the safety of apoaequorin, the protocol followed was very similar to Safety Study I, however in this instance the dosage amounts were much higher, up to 16,000 times the expected human daily consumption. Once again apoaequorin showed no adverse effects when taken orally.

Read The Summary

Do NOT follow this link or you will be banned from the site!
Interested in Prevagen?
Buy Direct from the Manufacturer
Don't miss out. Order Today.